Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calogero Vetro

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Biomolecules|January 28, 2026
BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune DisordersAndrea Duminuco, Paola De Luca, Gaia Stanzione, et al.
Hematology Reports|April 25, 2022
<i>Saprochete capitata</i>: Emerging Infections from Uncommon Microorganisms in Hematological DiseasesAndrea Duminuco, Calogero Vetro, Cinzia Maugeri, et al.
Cancers|January 11, 2022
Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough?Serena Brancati, Lucia Gozzo, Giovanni Luca Romano, et al.
British Journal of Haematology|November 8, 2014
Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategyAlessandra Romano, Nunziatina Laura Parrinello, Calogero Vetro, et al.
Frontiers in Oncology|June 9, 2015
Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor CellsCalogero Vetro, Alessandra Romano, Flavia Ancora, et al.
Radiology Case Reports|March 2, 2026
Endovascular management of pelvic congestion syndrome in males: A report of 2 casesDavide Giuseppe Castiglione, Placido Di Grigoli, Agata Amaduri, et al.
Frontiers in Oncology|March 3, 2023
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccineGiuseppe A Palumbo, Daniela Cambria, Enrico La Spina, et al.
Cancers|May 14, 2022
Target Therapy for Extramedullary Relapse of <i>FLT3</i>-ITD Acute Myeloid Leukemia: Emerging Data from the FieldAndrea Duminuco, Cinzia Maugeri, Marina Parisi, et al.
Biomed Research International|June 27, 2014
Salvage therapy of multiple myeloma: the new generation drugsAlessandra Romano, Concetta Conticello, Maide Cavalli, et al.
World Journal of Gastroenterology|October 4, 2014
Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-upCalogero Vetro, Alessandra Romano, Irene Amico, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Biomolecules|January 28, 2026
BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune DisordersAndrea Duminuco, Paola De Luca, Gaia Stanzione, et al.
Hematology Reports|April 25, 2022
<i>Saprochete capitata</i>: Emerging Infections from Uncommon Microorganisms in Hematological DiseasesAndrea Duminuco, Calogero Vetro, Cinzia Maugeri, et al.
Cancers|January 11, 2022
Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough?Serena Brancati, Lucia Gozzo, Giovanni Luca Romano, et al.
British Journal of Haematology|November 8, 2014
Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategyAlessandra Romano, Nunziatina Laura Parrinello, Calogero Vetro, et al.
Frontiers in Oncology|June 9, 2015
Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor CellsCalogero Vetro, Alessandra Romano, Flavia Ancora, et al.
Radiology Case Reports|March 2, 2026
Endovascular management of pelvic congestion syndrome in males: A report of 2 casesDavide Giuseppe Castiglione, Placido Di Grigoli, Agata Amaduri, et al.
Frontiers in Oncology|March 3, 2023
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccineGiuseppe A Palumbo, Daniela Cambria, Enrico La Spina, et al.
Cancers|May 14, 2022
Target Therapy for Extramedullary Relapse of <i>FLT3</i>-ITD Acute Myeloid Leukemia: Emerging Data from the FieldAndrea Duminuco, Cinzia Maugeri, Marina Parisi, et al.
Biomed Research International|June 27, 2014
Salvage therapy of multiple myeloma: the new generation drugsAlessandra Romano, Concetta Conticello, Maide Cavalli, et al.
World Journal of Gastroenterology|October 4, 2014
Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-upCalogero Vetro, Alessandra Romano, Irene Amico, et al.
Pageof 7